Sign in

CIK 0000939767 · Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
operating
EIN
043257395
Phone
6508377000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Planned sale Director sold 9,812 shares at $53.66 ($526,512)
  2. 4 Planned sale Director sold 3,925 shares at $50.55 ($198,409)
  3. 4 Planned sale Director sold 9,812 shares at $50.14 ($491,974)
  4. 4 Grant or award Director acquired 8,367 shares (grant or award)
  5. 4 Grant or award Director acquired 8,367 shares (grant or award)
  6. 4 Grant or award Director acquired 8,367 shares (grant or award)
  7. 4 Grant or award Director acquired 8,367 shares (grant or award)
  8. 4 Grant or award Director acquired 8,367 shares (grant or award)
  9. 4 Grant or award Director acquired 8,367 shares (grant or award)
  10. 4 Grant or award Director acquired 8,367 shares (grant or award)
  11. 4 Grant or award Director acquired 8,367 shares (grant or award)
  12. 4 Grant or award Director acquired 8,367 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale EVP, Research and Development sold 43,451 shares at $50.35 ($2,187,758)
  15. 4 Open-market sale EVP, Commercial sold 32,110 shares at $49.81 ($1,599,399)
  16. 4 Shares withheld for taxes President and CEO gave up 128,497 shares (to pay taxes)
  17. 4 Open-market sale EVP and CFO sold 34,901 shares at $50.00 ($1,745,050)
  18. 4 Shares withheld for taxes EVP, Commercial gave up 33,265 shares (to pay taxes)
  19. 4 Planned sale SVP and General Counsel sold 6,625 shares at $50.21 ($332,641)
  20. 4 Shares withheld for taxes EVP, Research and Development gave up 30,578 shares (to pay taxes)

Page 1 of 73 · 1,458 filings